In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.00% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,661.70 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.


.jpg)




